| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/29/2006 | CN1247582C Novel carbapenem compounds |
| 03/29/2006 | CN1247581C Processes for the preparation of carbapenem-type antibacterial agents |
| 03/29/2006 | CN1247579C Synthesizing nucleoside analog for antivirus |
| 03/29/2006 | CN1247576C Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/29/2006 | CN1247575C Sulfamino ether substituted imidazoquinolines |
| 03/29/2006 | CN1247573C Method for preparing arylacetyl aminothiazole |
| 03/29/2006 | CN1247567C 2-amino-3-(alkyl)-pyrimidone derivatives as GSKS beta. inhibitors |
| 03/29/2006 | CN1247554C Process for synthesizing ritonavir |
| 03/29/2006 | CN1247541C Cyclic imines as pesticides |
| 03/29/2006 | CN1247259C Recombinant human interferon alpha spray |
| 03/29/2006 | CN1247222C Pharmaceutical composition for treating AlDS |
| 03/29/2006 | CN1247204C Medicine for treating beri-beri |
| 03/29/2006 | CN1247200C Cefonicid sodium antibacterial composition |
| 03/29/2006 | CN1247197C Antibacterial combined medicine |
| 03/29/2006 | CN1247195C Silibinin oral disintegration tablet and its preparing method |
| 03/29/2006 | CN1247191C Hydroxy diphenyl ether compound |
| 03/29/2006 | CN1247188C Medicinal composition |
| 03/28/2006 | US7019135 For therapy of viral infection |
| 03/28/2006 | US7019123 Human bikunin |
| 03/28/2006 | US7019110 Streptogramin derivatives, preparation method and compositions containing same |
| 03/28/2006 | US7019030 Immunotherapeutic agents |
| 03/28/2006 | US7019026 Modulators of Protein Tyrosine Phosphatases (PTPases) |
| 03/28/2006 | US7019006 Compounds useful as anti-inflammatory agents |
| 03/28/2006 | US7019003 Bactericides |
| 03/28/2006 | US7019000 administering nitrogen-sulfur compounds, e.g. 4,4-dithiodimorpholine to inhibit binding of the E6 protein by human papilloma virus; treatment of cervical cancer |
| 03/28/2006 | US7018997 Tricyclic 6-alkylidene-penems as β-lactamase inhibitors |
| 03/28/2006 | US7018989 Chemical compounds |
| 03/28/2006 | US7018988 Pharmaceutically active pyrrolidine derivatives as Bax inhibitors |
| 03/28/2006 | US7018985 Composition and method for inhibiting platelet aggregation |
| 03/28/2006 | US7018796 Detection of modulators of viral enzymatic activity; obtain sample containing viral enzyme, incubate with modulator and substrate, monitor adjustment in enzyme activity |
| 03/28/2006 | US7018661 Aluminum-zirconium compound-based treatment for herpes simplex virus lesions |
| 03/28/2006 | US7018656 Gel formulations of 1-hydroxy-2(H)pyridone derivatives, which contain solvents and hydrophilic gel-forming agents |
| 03/28/2006 | US7018640 Vaccinating a domesticated bird against coccidiosis comprising administering in ovo, during the final quarter of incubation, an effective immunizing dose of live Eimeria sporozoites or merozoites, or a mixture |
| 03/28/2006 | US7018638 Mycoplasma hyopneumoniae bacterin vaccine |
| 03/28/2006 | US7018637 Vaccines; immunology carrier containing epitope binding tocarbohydrates |
| 03/28/2006 | US7018620 Delivery of beta-blockers through an inhalation route |
| 03/28/2006 | CA2415750C Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 03/28/2006 | CA2372960C Hiv immunogenic compositions and methods |
| 03/28/2006 | CA2343459C Pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/28/2006 | CA2309551C Aminothiazole inhibitors of cyclin dependent kinases |
| 03/28/2006 | CA2120374C 9-[(substituted glycyl) amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| 03/23/2006 | WO2006030925A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 03/23/2006 | WO2006030807A1 Carbamoylpyridone derivative having hiv integrase inhibitory activity |
| 03/23/2006 | WO2006030299A1 Processes for the preparation of polymorphs of efavirenz |
| 03/23/2006 | WO2006030297A1 Taste masked granules comprising clarithromycin, hydrocolloids and a coating |
| 03/23/2006 | WO2006029912A1 Indole derivatives as antiviral agents |
| 03/23/2006 | WO2006029811A1 Method for manufacturing enantiomeric imidazole compounds |
| 03/23/2006 | WO2006029507A1 Inhibition of feline calicivirus replication by asparaginase |
| 03/23/2006 | WO2005117956A3 Neisserial vaccines |
| 03/23/2006 | WO2005023819A9 Thienopyrroles as antiviral agents |
| 03/23/2006 | WO2005003325A3 Inhibition of viral pathogenesis |
| 03/23/2006 | US20060063843 Compounds for the treatment of inflammatory disorders |
| 03/23/2006 | US20060063835 Composition based on triethyl citrate for the treatment of bacterial infections of the skin |
| 03/23/2006 | US20060063806 4-(4,5,6-trimethoxy-2-benzaldehyde) coumarin; fungicides, nontoxic |
| 03/23/2006 | US20060063787 Condensed imidazole derivatives |
| 03/23/2006 | US20060063782 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors |
| 03/23/2006 | US20060063778 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 03/23/2006 | US20060063771 CCR5 antagonists useful for treating AIDS |
| 03/23/2006 | US20060063763 Compounds and methods for modulating CXCR3 function |
| 03/23/2006 | US20060063748 Methods for treating psychosis associated with interferson-alpha therapy |
| 03/23/2006 | US20060063706 Bactericides with antibacterial activity and an improved mammalian safety profile; exhibit reduced tissue accumulation and/or nephrotoxicity when administered to mammals; treating infection caused by methicillin-resistant Staphylococcus aureus |
| 03/23/2006 | US20060063699 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 03/23/2006 | US20060063167 DNA and proteins or peptides specific of the Neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 03/23/2006 | US20060062809 Solid dispersions comprising two different polymer matrixes |
| 03/23/2006 | US20060062807 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 03/23/2006 | US20060062805 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
| 03/23/2006 | US20060062803 a nucleic acid fhaving a first nucleotide sequence encoding nonstructural proteins from attenuated dengue-2 virus vaccine strain PDK-53, and a second nucleotide sequence encoding a structural protein from a second flavivirus; amino acid mutations in the nontstructural proteins; vaccines |
| 03/23/2006 | US20060062802 Medicinal product |
| 03/23/2006 | US20060062799 Sperm specific lysozyme-like proteins |
| 03/23/2006 | US20060062771 Therapeutic autologous-cell delivery support system, financial system for use therewith, and method therefor |
| 03/23/2006 | DE10344561A1 Use of proteins and peptides from royal jelly, as antibacterial, fungicidal and antiviral agents, where activity is associated with short amino acid sequences |
| 03/23/2006 | CA2823429A1 Sialidase catalytic domain proteins |
| 03/23/2006 | CA2583199A1 The use of an inhibitor of heterotetrameric annexin 2 for treating viral infections |
| 03/23/2006 | CA2580319A1 Vaccine |
| 03/23/2006 | CA2579923A1 Anti-parasitic and/or anti-viral and/or anti-microbial compositions |
| 03/23/2006 | CA2579501A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 03/23/2006 | CA2579141A1 Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease |
| 03/23/2006 | CA2574719A1 Inhibition of feline calicivirus replication by asparaginase |
| 03/23/2006 | CA2568832A1 Indole derivatives as antiviral agents |
| 03/22/2006 | EP1637611A1 Method for producing oligosaccharides |
| 03/22/2006 | EP1637593A1 Process for the inactivation of enveloped viruses |
| 03/22/2006 | EP1637591A1 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoc |
| 03/22/2006 | EP1637528A1 Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease |
| 03/22/2006 | EP1637518A2 Inhibitors of aspartyl protease |
| 03/22/2006 | EP1637164A2 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 03/22/2006 | EP1637160A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 03/22/2006 | EP1637158A2 Capsular polysaccharide immunomodulator |
| 03/22/2006 | EP1637139A2 Novel use of HIV protease inhibiting compounds |
| 03/22/2006 | EP1637132A1 External preparation for athlete´s foot treatment |
| 03/22/2006 | EP1636240A1 Beta-lactamase inhibitor prodrug |
| 03/22/2006 | EP1636229A2 A1 adenosine receptor antogonists |
| 03/22/2006 | EP1636190A1 Stable crystal of 4-oxoquinoline compound |
| 03/22/2006 | EP1636171A2 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator |
| 03/22/2006 | EP1635891A2 Pharmaceutical composition to prevent and treat epithelial wounds, immunomodulating pharmaceutical composition, pharmaceutical composition, insecticide, insecticide composition, insecticide use of lectin km+ to treat cicatrizations, use of lectin km+ to prepare immunomodulating medicament |
| 03/22/2006 | EP1635854A2 Treatment or prevention of respiratory viral infections with alpha thymosin peptides |
| 03/22/2006 | EP1635827A1 Pyridine n-oxides as antiviral agents |
| 03/22/2006 | EP1635802A1 Method for inhibiting the growth of antibiotic-resistant of bacteria by using pentane-1,5-diol |
| 03/22/2006 | EP1635799A2 Pharmaceutical formulations of amyloid inhibiting compounds |
| 03/22/2006 | EP1472221B1 Substituted indoles, method for production and use thereof for the inhibition of pain |
| 03/22/2006 | EP1412357B1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |